Buy or sell Epic Sciences stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Epic Sciences Stock

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

About Epic Sciences Stock

Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine. Epic is founded on a powerful platform to identify and characterize rare cells including circulating tumor cells ("CTCs"). Epic is working with a number of partners including numerous pharmaceutical companies, major cancer centers, the National Cancer Institute, and the National Institutes of Health.

Funding History

June 2009$2.5M
November 2012$13.0M
July 2014$30.0M
June 2015$15.0M
April 2017$40.0M
September 2018$52.0M

Management

Chief Business Officer and General Counsel

Ian Miller

Chief of Medical Innovation; Head of Translational Research Partnerships

Ryan Dittamore

CSO & Head of Laboratory Operations

Pascal Bamford

Founder

David Nelson

CEO & President

Murali K. Prahalad

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Epic Sciences or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 140K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo